# Amundi EURO STOXX 50 Daily (-2X) Inverse UCITS ETF Act -Acc- (0MRL) **Page:** https://fundology.uk/fund/0mrl · ISIN FR0010424143 ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 13/11/2026, 0MRL (Amundi EURO STOXX 50 Daily (-2X) Inverse UCITS ETF Act -Acc-, ISIN FR0010424143) closed at €0.4008 on the London Stock Exchange. Its ongoing charge is 0.60% a year (about £60 on £10,000). Over the five years to 13/11/2026 its total return was −70.4%, or −76.9% after UK CPIH inflation. ## Summary Amundi EURO STOXX 50 Daily (-2X) Inverse UCITS ETF Act -Acc- is an exchange-traded fund (ETF) from Amundi, launched in 2007. It aims to deliver a multiple, or the opposite, of one day’s move in what it tracks. The multiple resets daily, so over longer periods its return can differ a lot from the multiple of the index return. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.6% a year — about £60 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. > **Leveraged & inverse:** Built for short-term trading. Because the multiple resets every day, losses can build up quickly when held for longer, even if the index ends up where it started. Latest close: **€0.4008** (13/11/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | 0MRL | | ISIN | FR0010424143 | | Also listed as | LSK8 (Xetra, euros) | | Category | Leveraged & inverse | | Type | ETF | | Provider | Amundi | | Tracks | EURO STOXX 50 Daily Double Short - EUR - Benchmark TR Gross | | Income | Accumulating | | Ongoing charge | 0.60% a year (£60 per £10,000) | | Fund size | £24.3m | | Launched | 2007 | | Domicile | France | | UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 06/09/2018 | ## Past returns (periods to 13/11/2026) After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation. | Window | Return | After CPIH inflation | Measured as | |---|---|---|---| | 1 year | -27.16% | -29.74% | income reinvested | | 3 years | -62.02% | -65.69% | income reinvested | | 5 years | -70.41% | -76.90% | income reinvested | Returns: as reported (delayed data). Inflation: UK CPIH, latest month published. ## Calendar-year returns Calendar-year returns of Amundi EURO STOXX 50 Daily (-2X) Inverse UCITS ETF Act -Acc- in pounds (price, with income reinvested in the fund): 2022 +4.9%, 2023 −32.2%, 2024 −17.7%, 2025 −31.8%; 2026 to 13/11/2026 −24.8%. Returns of Amundi EURO STOXX 50 Daily (-2X) Inverse UCITS ETF Act -Acc- in pounds (price, with income reinvested in the fund) over the 12 months to 30/09/2026: −25.2%; to 30/09/2025: −22.3%; to 30/09/2024: −33.3%; to 30/09/2023: −42.9%; to 30/09/2022: +19.8%. | Year | Return | After CPIH inflation | Measured as | |---|---|---|---| | 2022 | +4.9% | -4.0% | Price | | 2023 | -32.2% | -34.9% | Price | | 2024 | -17.7% | -20.5% | Price | | 2025 | -31.8% | -34.1% | Price | | 2026 to 13/11/2026 | -24.8% | -27.2% | Price | ## Risk metrics | Window | Volatility | Max drawdown | |---|---|---| | 1 year | 29.51% | -34.09% | | 3 years | 29.95% | -65.04% | | 5 years | 33.01% | -79.69% | ## Largest fall Volatility of Amundi EURO STOXX 50 Daily (-2X) Inverse UCITS ETF Act -Acc- in pounds, annualised from weekly returns to 13/11/2026: 29.5% over 1 year, 29.9% over 3 years, 33.0% over 5 years. Largest fall in the price of Amundi EURO STOXX 50 Daily (-2X) Inverse UCITS ETF Act -Acc- since November 2021, in pounds: −79.7% from 30/09/2022 to 14/08/2026. The lowest 12-month return of Amundi EURO STOXX 50 Daily (-2X) Inverse UCITS ETF Act -Acc- in pounds (price, with income reinvested in the fund) since January 2021 was −45.7% (12 months to 16/06/2023); the highest was +24.5% (12 months to 23/09/2022). On 13/11/2026 the price of Amundi EURO STOXX 50 Daily (-2X) Inverse UCITS ETF Act -Acc- was 79.1% below its highest weekly close since November 2021 (30/09/2022), in pounds. ## Charges compared with similar funds Ongoing charge of Amundi EURO STOXX 50 Daily (-2X) Inverse UCITS ETF Act -Acc- 0.60% a year. Compared on 14/11/2026, 171 of the 210 other leveraged and inverse products charge more, 13 the same and 26 less (share classes counted once). ## Charges & eligibility - Ongoing charges figure (OCF): **0.60%** per year (as of 13/11/2026) - Stocks and shares ISA eligible: usually (check with your platform) - SIPP eligible: usually (check with your provider) - ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify. ## What it holds 0MRL is a swap-based (synthetic) fund: it gets the return of the index it tracks through a swap. Its published holdings, as of 11/11/2026, are the substitute basket of securities the fund holds as collateral, not the companies in that index. ### Top holdings Largest positions (as of 11/11/2026), as a percentage of the whole fund: | # | Holding | Ticker | Weight | |---|---|---|---| | 1 | Coca-Cola | [KO](https://fundology.uk/stock/KO) | 8.36% | | 2 | Amazon | [AMZN](https://fundology.uk/stock/AMZN) | 8.25% | | 3 | Aegon | [AGN](https://fundology.uk/stock/AGN) | 5.51% | | 4 | MetLife | [MET](https://fundology.uk/stock/MET) | 5.15% | | 5 | Bank of America | [BAC](https://fundology.uk/stock/BAC) | 4.83% | | 6 | Home Depot | [HD](https://fundology.uk/stock/HD) | 4.55% | | 7 | Ferrovial | [FER](https://fundology.uk/stock/FER) | 4.52% | | 8 | Qiagen | [QGEN](https://fundology.uk/stock/QGEN) | 4.50% | | 9 | Newmont | [NEM](https://fundology.uk/stock/NEM) | 4.45% | | 10 | Intuitive Surgical | [ISRG](https://fundology.uk/stock/ISRG) | 4.32% | The 34 holdings on record (of 35 reported): https://fundology.uk/fund/0mrl/holdings ## Questions people ask **What is the ongoing charge of 0MRL?** The ongoing charge of 0MRL is 0.60% a year — about £60 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Amundi EURO STOXX 50 Daily (-2X) Inverse UCITS ETF Act -Acc- 0.60% a year. Compared on 14/11/2026, 171 of the 210 other leveraged and inverse products charge more, 13 the same and 26 less (share classes counted once). **What does 0MRL track?** 0MRL tracks the EURO STOXX 50 Daily Double Short. **Is 0MRL accumulating or distributing?** 0MRL is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. **What is the ISIN of 0MRL?** The ISIN of 0MRL is FR0010424143. An ISIN identifies one exact share class of a fund; 0MRL is its ticker on the London Stock Exchange. The same share class is also listed as LSK8 (Xetra, euros). **What does 0MRL hold?** 0MRL is a swap-based (synthetic) fund: it gets the return of the index it tracks through a swap. Its published holdings, as of 11/11/2026, are the substitute basket of securities the fund holds as collateral, not the companies in that index. **What were 0MRL’s returns in each of the last five years?** Calendar-year returns of 0MRL in pounds (price, with income reinvested in the fund): 2022 +4.9%, 2023 −32.2%, 2024 −17.7%, 2025 −31.8%; 2026 to 13/11/2026 −24.8%. Past performance is not a guide to future returns. **How has 0MRL done after inflation?** Over the five years to 13/11/2026 0MRL’s total return was −70.4%, or −76.9% after UK CPIH inflation. Past performance is not a guide to future returns. ## Fund documents - [Fund page at Amundi](https://www.amundietf.co.uk/en/professional/products/equity/amundi-euro-stoxx-50-daily-2x-inverse-ucits-etf-acc/fr0010424143) - Links checked 12/10/2026. --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.